Announced
Financials
Sources
Tags
Cross Border
Friendly
Single Bidder
Private
Majority
Acquisition
Pending
Pharmaceuticals
pharmaceuticals & biotechnology
Switzerland
Private Equity
Synopsis
Abu Dhabi Development, a holding company, agreed to acquire Acino, a Swiss pharmaceutical company, from private equity firms Nordic Capital and Avista Capital Partners. Financial terms were not disclosed. Acino is committed to advancing the development of healthcare by enhancing access to high-quality medicines that patients and governments can trust and value, and ADQ’s support will accelerate this ambition. Having built a solid reputation as a leading provider of advanced pharmaceutical solutions in emerging markets, we are excited about the opportunity for business transformation and commercial growth potential as Acino joins ADQ’s healthcare and pharma portfolio," Steffen Saltofte, Acino CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.